Edrophonium Chloride Intravenous Injection 10mg (Antirex® / アンチレクス静注10mg)

JPY ¥1,700

Japanese Diagnostic Agent (Edrophonium Chloride 10mg). Intravenous injection for diagnosis of myasthenia gravis and differential diagnosis of prolonged respiratory depression following neuromuscular blockade. 10 ampoules per pack. Mfd. by Kyorin Pharmaceutical Co., Ltd., Japan.

Bulk deal
Quantity Discount Discounted price
5 - 9 8% JPY ¥1,564
10 - 19 12% JPY ¥1,496
20 + 18% JPY ¥1,394
SKU: ANT-10-INJ Category:

Description

Product Overview / 商品概要

Antirex Intravenous Injection 10mg (アンチレクス静注10mg)
Generic: Edrophonium Chloride / エドロホニウム塩化物
Therapeutic Category: Diagnostic Agent / 機能検査用薬
Manufactured by: Kyorin Pharmaceutical Co., Ltd. / 杏林製薬株式会社

Composition & Specification / 組成・規格

Active Ingredient: Edrophonium Chloride (JP) 10mg per 1mL ampoule / 1アンプル1mL中 日局 エドロホニウム塩化物10mg
Additives: Dried Sodium Sulfite 2mg, Tonicity agent 4.7mg / 乾燥亜硫酸ナトリウム2mg、等張化剤4.7mg
Appearance: Colorless clear solution; pH 6.5–8.0; Osmolarity ratio approximately 1 (relative to physiological saline)
外観: 無色澄明の液、pH 6.5~8.0、浸透圧比(生理食塩液に対する比)約1

Indications / 効能効果

EN: Diagnosis of myasthenia gravis; differential diagnosis of the mechanism of prolonged respiratory depression following administration of neuromuscular blocking agents
JA: 重症筋無力症の診断、筋弛緩剤投与後の遷延性呼吸抑制の作用機序の鑑別診断

Dosage and Administration / 用法用量

EN: For diagnosis of myasthenia gravis: The usual adult dose is 10mg of edrophonium chloride administered intravenously. Initially, 2mg is injected over 15–30 seconds; after 45 seconds, the response is assessed and the remaining 8mg is injected if necessary. For differential diagnosis of the mechanism of prolonged respiratory depression following neuromuscular blocking agents: The usual adult dose is 5–10mg administered intravenously over 30–40 seconds. If neuromuscular blockade improves, the block is classified as non-depolarizing; if it worsens, as depolarizing. If necessary, the same dose may be repeated within 5–10 minutes. Dosage should be adjusted according to age.
JA: 重症筋無力症の診断には、エドロホニウム塩化物として、通常成人1回10mgを静脈内注射する。その際、まず初めに2mgを15~30秒かけて注射し、45秒後に反応をみた上で必要に応じて残りの8mgを注射する。筋弛緩剤投与後の遷延性呼吸抑制の作用機序の鑑別診断には、エドロホニウム塩化物として、通常成人5~10mgを30~40秒かけて静脈内注射する。筋弛緩状態が改善されれば非脱分極性ブロック、筋弛緩状態が増強されれば脱分極性ブロックと判定する。必要があれば5~10分以内に同量を反復投与する。なお、年齢により適宜増減する。

Contraindications / 禁忌

EN: Patients with organic obstruction of the gastrointestinal tract or urinary tract
JA: 消化管又は尿路の器質的閉塞のある患者

Regulatory Information / 規制情報

Approval No.: 22000AMX00661000
Sales Started: October 1960 / 1960年10月
Classification Code: 877229
Storage: Store at room temperature / 室温保存
Shelf Life: 5 years / 5年

Packaging / 包装

Main Package (for sale): 10 ampoules / 10アンプル
Other Available Packages (by special order): 10 ampoules

Full product insert (添付文書) is attached as a downloadable PDF. For detailed precautions, drug interactions, and safety information, please refer to the official package insert.

Additional information

重さ 0.15 kg

Reviews

There are no reviews yet.

Be the first to review “Edrophonium Chloride Intravenous Injection 10mg (Antirex® / アンチレクス静注10mg)”

メールアドレスが公開されることはありません。 ※ が付いている欄は必須項目です

Export from Japan — Edrophonium Chloride Intravenous Injection 10mg (Antirex®

🏭 Supply & Origin

  • Country of Origin: Japan
  • Regulatory Standard: PMDA (Japan) / GMP Compliant
  • Pharmacopoeia: Japanese Pharmacopoeia (JP)
  • Supplier: Mate Co., Ltd. — Licensed Pharmaceutical Wholesaler (License No. B14309, Osaka)
  • Supply Capacity: Full-line sourcing through Japan's regulated distribution channels

🚚 Shipping & Trade Terms

  • Incoterms: FOB Kansai International Airport (KIX)
  • Shipping: Air freight via B/L or AWB
  • Payment: 100% T/T in advance
  • Lead Time: 2-4 weeks after payment confirmation
  • Available Regions: EU, LATAM, APAC, Middle East, Africa

Request a Quotation

For pricing, MOQ, and regulatory documentation, contact our export team:

Email: kurimoto@mate-osaka.co.jp
Tel: +81-72-665-5736

All exports are conducted through proper regulatory procedures including customs clearance, B/L or AWB documentation, and T/T advance payment. We do not engage in hand-carry, cash transactions, or sales to unlicensed parties.